Novel cytotoxic Rhodium and Iridium Compounds and their use as anticancer drugs and antimetastatic agents
These novel rhodium complexes were tested on breast cancer (MCF-7) and colon cancer (HT-29) cell lines and exhibit cytotoxicities of up to 100 times higher than Cisplatin.
Further Information: PDF
rubitec – Gesellschaft für Innovation und Technologie der Ruhr-Universität Bochum mbH
Phone: +49 (0)234/32-11969/11950
Contact
Dietmar Tappe
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Retinoblastoma: Eye-Catching Investigation into Retinal Tumor Cells
A research team from the Medical Faculty of the University of Duisburg-Essen and the University Hospital Essen has developed a new cell culture model that can be used to better…
A Job Well Done: How Hiroshima’s Groundwater Strategy Helped Manage Floods
Groundwater and multilevel cooperation in recovery efforts mitigated water crisis after flooding. Converting Disasters into Opportunities Society is often vulnerable to disasters, but how humans manage during and after can…
Shaping the Future: DNA Nanorobots That Can Modify Synthetic Cells
Scientists at the University of Stuttgart have succeeded in controlling the structure and function of biological membranes with the help of “DNA origami”. The system they developed may facilitate the…